Alicia Gil

Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA)

A. Delgado Jiménez, Arantza Ais, Amélie Beaudet et al. · Orphanet Journal of Rare Diseases · 2018 · 39 citations · Full text

Multi-Criteria Decision Analysis (MCDA): Common Tools for Different Needs Supporting Healthcare Decision Making in Spain

A Gilabert-Perramon, C Lens, JI Betolaza et al. · Value in Health · 2016 · 25 citations

Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain

Vicente Villanueva, José M. Serratosa, Manuel Toledo et al. · Epilepsy & Behavior · 2023 · 18 citations · Full text

PHP169 - MCDA EVIDEM REFERENCE VALUE FRAMEWORK FOR DRUG EVALUATION AND DECISION MAKING IN SPAIN

Xavier Badía, Alicia Gil, J. Shepherd · Value in Health · 2018 · 16 citations

Drug Safety, Drug Discovery, Pharmacology +4